Share on StockTwits

Agios Pharmaceuticals (NASDAQ:AGIO) SVP Glenn Goddard sold 10,000 shares of the company’s stock on the open market in a transaction dated Tuesday, January 21st. The stock was sold at an average price of $34.71, for a total value of $347,100.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Agios Pharmaceuticals (NASDAQ:AGIO) traded down 6.69% on Wednesday, hitting $29.86. The stock had a trading volume of 428,560 shares. Agios Pharmaceuticals has a 1-year low of $15.77 and a 1-year high of $44.04. The stock’s 50-day moving average is $24.94 and its 200-day moving average is $25.41. The company’s market cap is $930.8 million.

Agios Pharmaceuticals (NASDAQ:AGIO) last issued its quarterly earnings data on Thursday, November 7th. The company reported ($0.47) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.28) by $0.19. Analysts expect that Agios Pharmaceuticals will post $-1.62 EPS for the current fiscal year.

Agios Pharmaceuticals, Inc is a biopharmaceutical company. The Company is intend to apply its deep understanding of metabolism, coupled with the Company’s ability to create medicines that can inhibit or activate metabolic enzymes, to fundamentally change the way cancer and inborn errors of metabolism (NASDAQ:AGIO) are treated.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.